Combined gene expression analysis of whole-tissue and microdissected pancreatic ductal adenocarcinoma identifies genes specifically overexpressed in tumor epithelia
- PMID: 19260470
Combined gene expression analysis of whole-tissue and microdissected pancreatic ductal adenocarcinoma identifies genes specifically overexpressed in tumor epithelia
Abstract
Background/aims: The precise details of pancreatic ductal adenocarcinoma (PDAC) pathogenesis are still insufficiently known, requiring the use of high-throughput methods. However, PDAC is especially difficult to study using microarrays due to its strong desmoplastic reaction, which involves a hyperproliferating stroma that effectively "masks" the contribution of the minoritary neoplastic epithelial cells. Thus it is not clear which of the genes that have been found differentially expressed between normal and whole tumor tissues are due to the tumor epithelia and which simply reflect the differences in cellular composition. To address this problem, laser microdissection studies have been performed, but these have to deal with much smaller tissue sample quantities and therefore have significantly higher experimental noise.
Methodology: In this paper we combine our own large sample whole-tissue study with a previously published smaller sample microdissection study by Grützmann et al. to identify the genes that are specifically overexpressed in PDAC tumor epithelia.
Results: The overlap of this list of genes with other microarray studies of pancreatic cancer as well as with the published literature is impressive. Moreover, we find a number of genes whose over-expression appears to be inversely correlated with patient survival: keratin 7, laminin gamma 2, stratifin, platelet phosphofructokinase, annexin A2, MAP4K4 and OACT2 (MBOAT2), which are all specifically upregulated in the neoplastic epithelia, rather than the tumor stroma.
Conclusions: We improve on other microarray studies of PDAC by putting together the higher statistical power due to a larger number of samples with information about cell-type specific expression and patient survival.
Similar articles
-
Expression of MAP4K4 is associated with worse prognosis in patients with stage II pancreatic ductal adenocarcinoma.Clin Cancer Res. 2008 Nov 1;14(21):7043-9. doi: 10.1158/1078-0432.CCR-08-0381. Clin Cancer Res. 2008. PMID: 18981001
-
Identification of genes whose expression is upregulated in lung adenocarcinoma cells in comparison with type II alveolar cells and bronchiolar epithelial cells in vivo.Oncogene. 2004 Apr 15;23(17):3089-96. doi: 10.1038/sj.onc.1207433. Oncogene. 2004. PMID: 14755238
-
Molecular profiling of pancreatic adenocarcinoma and chronic pancreatitis identifies multiple genes differentially regulated in pancreatic cancer.Cancer Res. 2003 May 15;63(10):2649-57. Cancer Res. 2003. PMID: 12750293
-
Critical role of laser microdissection for genetic, epigenetic and proteomic analyses in pancreatic cancer.Expert Rev Mol Diagn. 2011 Sep;11(7):695-701. doi: 10.1586/erm.11.62. Expert Rev Mol Diagn. 2011. PMID: 21902531 Review.
-
Pancreatic adenocarcinoma -- genetic portrait from chromosomes to microarrays.Genes Chromosomes Cancer. 2006 Aug;45(8):721-30. doi: 10.1002/gcc.20337. Genes Chromosomes Cancer. 2006. PMID: 16688744 Review.
Cited by
-
Lymphocyte antigen 6 family member E suppresses apoptosis and promotes pancreatic cancer growth and migration via Wnt/β-catenin pathway activation.Sci Rep. 2024 Aug 30;14(1):20196. doi: 10.1038/s41598-024-70764-1. Sci Rep. 2024. PMID: 39215036 Free PMC article.
-
Implication of Capillary Morphogenesis Gene 2 (CMG2) in the Disease Progression and Peritoneal Metastasis of Pancreatic Cancer.Cancers (Basel). 2024 Aug 20;16(16):2893. doi: 10.3390/cancers16162893. Cancers (Basel). 2024. PMID: 39199664 Free PMC article.
-
Multilevel Regulation of NF-κB Signaling by NSD2 Suppresses Kras-Driven Pancreatic Tumorigenesis.Adv Sci (Weinh). 2024 Aug;11(30):e2309387. doi: 10.1002/advs.202309387. Epub 2024 Jun 18. Adv Sci (Weinh). 2024. PMID: 38889281 Free PMC article.
-
Transcriptome analysis reveals PRKCA as a potential therapeutic target for overcoming cisplatin resistance in lung cancer through ferroptosis.Heliyon. 2024 May 7;10(10):e30780. doi: 10.1016/j.heliyon.2024.e30780. eCollection 2024 May 30. Heliyon. 2024. PMID: 38765024 Free PMC article.
-
Comprehensive analysis based on the disulfidptosis-related genes identifies hub genes and immune infiltration for pancreatic adenocarcinoma.Open Med (Wars). 2024 Mar 4;19(1):20240906. doi: 10.1515/med-2024-0906. eCollection 2024. Open Med (Wars). 2024. PMID: 38463521 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical
Research Materials
Miscellaneous